Novartis licenses lipoprotein-lowering CVD drug - pharmaphorum https://t.co/LUSzzkz51J
— IDRO (@IDROOhio) February 25, 2019
from Twitter https://twitter.com/IDROOhio
February 25, 2019 at 02:13AM
Novartis licenses lipoprotein-lowering CVD drug - pharmaphorum https://t.co/LUSzzkz51J
— IDRO (@IDROOhio) February 25, 2019
No comments:
Post a Comment